Cytosorbents Return on Tangible Equity 2010-2025 | CTSO
Current and historical return on tangible equity values for Cytosorbents (CTSO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Cytosorbents Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.02B | $0.02B | -107.14% |
| 2024-12-31 | $-0.02B | $0.01B | -133.33% |
| 2024-09-30 | $-0.02B | $0.01B | -105.56% |
| 2024-06-30 | $-0.03B | $0.02B | -133.33% |
| 2024-03-31 | $-0.03B | $0.02B | -131.76% |
| 2023-12-31 | $-0.03B | $0.02B | -122.11% |
| 2023-09-30 | $-0.02B | $0.02B | -85.98% |
| 2023-06-30 | $-0.03B | $0.02B | -81.89% |
| 2023-03-31 | $-0.03B | $0.03B | -82.12% |
| 2022-12-31 | $-0.03B | $0.04B | -74.58% |
| 2022-09-30 | $-0.04B | $0.04B | -80.00% |
| 2022-06-30 | $-0.04B | $0.05B | -59.07% |
| 2022-03-31 | $-0.03B | $0.06B | -44.11% |
| 2021-12-31 | $-0.02B | $0.06B | -33.68% |
| 2021-09-30 | $-0.02B | $0.07B | -21.26% |
| 2021-06-30 | $-0.01B | $0.07B | -14.19% |
| 2021-03-31 | $-0.01B | $0.08B | -13.85% |
| 2020-12-31 | $-0.01B | $0.08B | -15.69% |
| 2020-09-30 | $-0.01B | $0.08B | -34.38% |
| 2020-06-30 | $-0.02B | $0.02B | -123.64% |
| 2020-03-31 | $-0.02B | $0.02B | -167.44% |
| 2019-12-31 | $-0.02B | $0.00B | -216.22% |
| 2019-09-30 | $-0.02B | $0.01B | -164.71% |
| 2019-06-30 | $-0.02B | $0.01B | -106.25% |
| 2019-03-31 | $-0.02B | $0.02B | -102.70% |
| 2018-12-31 | $-0.02B | $0.02B | -93.15% |
| 2018-09-30 | $-0.02B | $0.02B | -90.91% |
| 2018-06-30 | $-0.01B | $0.02B | -101.82% |
| 2018-03-31 | $-0.01B | $0.01B | -97.56% |
| 2017-12-31 | $-0.01B | $0.01B | -144.00% |
| 2017-09-30 | $-0.01B | $0.01B | -275.00% |
| 2017-06-30 | $-0.01B | $0.01B | -550.00% |
| 2017-03-31 | $-0.01B | $0.00B | -1200.00% |
| 2016-12-31 | $-0.01B | $0.00B | -400.00% |
| 2016-09-30 | $-0.01B | $0.00B | -210.53% |
| 2016-06-30 | $-0.01B | $0.00B | -162.96% |
| 2016-03-31 | $-0.01B | $0.01B | -80.00% |
| 2015-12-31 | $-0.01B | $0.01B | -102.56% |
| 2015-09-30 | $-0.02B | $0.01B | -194.29% |
| 2015-06-30 | $-0.02B | $0.01B | -200.00% |
| 2015-03-31 | $-0.02B | $0.01B | -280.00% |
| 2014-12-31 | $-0.02B | $0.00B | -248.28% |
| 2014-09-30 | $-0.01B | $0.01B | -138.46% |
| 2014-06-30 | $-0.01B | $0.01B | -147.37% |
| 2014-03-31 | $-0.01B | $0.01B | -200.00% |
| 2013-12-31 | $-0.01B | $0.00B | -480.00% |
| 2013-09-30 | $-0.01B | $0.00B | -480.00% |
| 2013-06-30 | $-0.01B | $0.00B | -480.00% |
| 2013-03-31 | $-0.01B | $0.00B | -480.00% |
| 2012-12-31 | $-0.01B | $0.00B | -600.00% |
| 2012-09-30 | $-0.01B | $0.00B | -800.00% |
| 2012-06-30 | $-0.01B | $0.00B | -933.33% |
| 2012-03-31 | $-0.01B | $0.00B | -700.00% |
| 2011-12-31 | $-0.01B | $0.00B | -700.00% |
| 2011-09-30 | $-0.01B | $0.00B | -600.00% |
| 2011-06-30 | $-0.01B | $0.00B | -1000.00% |
| 2011-03-31 | $0.00B | $0.00B | 0.00% |
| 2010-12-31 | $0.00B | $0.00B | 1200.00% |
| 2010-09-30 | $0.00B | $0.00B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | -1200.00% |
| 2010-03-31 | $0.00B | $0.00B | -600.00% |
| 2009-12-31 | $0.00B | $0.00B | -300.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.053B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.550B | 25.75 |
| Boston Scientific (BSX) | United States | $155.224B | 37.07 |
| Stryker (SYK) | United States | $149.901B | 30.56 |
| EssilorLuxottica (ESLOY) | France | $137.930B | 0.00 |
| Medtronic (MDT) | Ireland | $115.737B | 16.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.985B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.363B | 24.18 |
| ResMed (RMD) | United States | $39.874B | 28.48 |
| Agilent Technologies (A) | United States | $32.613B | 21.26 |
| GE HealthCare Technologies (GEHC) | United States | $32.562B | 15.31 |
| Koninklijke Philips (PHG) | Netherlands | $25.229B | 16.69 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Insulet (PODD) | United States | $20.296B | 79.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.133B | 11.65 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.385B | 0.00 |
| Baxter (BAX) | United States | $11.167B | 8.63 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.584B | 24.05 |
| Lantheus Holdings (LNTH) | United States | $4.925B | 12.42 |
| Perrigo (PRGO) | Ireland | $3.667B | 9.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.654B | 16.33 |
| Haemonetics (HAE) | United States | $3.557B | 16.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.202B | 21.97 |
| ICU Medical (ICUI) | United States | $3.160B | 23.31 |
| LeMaitre Vascular (LMAT) | United States | $1.836B | 41.03 |
| AtriCure (ATRC) | United States | $1.745B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.557B | 10.71 |
| Acuren (TIC) | United States | $1.347B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.251B | 28.14 |
| AdaptHealth (AHCO) | United States | $1.210B | 12.29 |
| Phibro Animal Health (PAHC) | United States | $1.074B | 13.73 |
| BioLife Solutions (BLFS) | United States | $1.017B | 0.00 |
| Neogen (NEOG) | United States | $1.010B | 16.03 |
| Curaleaf Holdings (CURLF) | Canada | $0.905B | 0.00 |
| InMode (INMD) | Israel | $0.863B | 7.99 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.625B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.585B | 0.00 |
| Evolus (EOLS) | United States | $0.575B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.44 |
| ZimVie (ZIMV) | United States | $0.523B | 20.42 |
| CeriBell (CBLL) | United States | $0.520B | 0.00 |
| Surmodics (SRDX) | United States | $0.513B | 0.00 |
| SNDL (SNDL) | Canada | $0.452B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.374B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.330B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.300B | 11.03 |
| Quanterix (QTRX) | United States | $0.297B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
| Cerus (CERS) | United States | $0.245B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.241B | 20.30 |
| Omeros (OMER) | United States | $0.239B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.238B | 0.00 |
| Biote (BTMD) | United States | $0.223B | 6.26 |
| Brainsway (BWAY) | Israel | $0.221B | 58.40 |
| Sanara MedTech (SMTI) | United States | $0.215B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.211B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.205B | 0.00 |
| Exagen (XGN) | United States | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.87 |
| Organigram Global (OGI) | Canada | $0.180B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.176B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.160B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.124B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.117B | 14.45 |
| Jushi Holdings (JUSHF) | United States | $0.111B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| MacroGenics (MGNX) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.49 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Safety Shot (SHOT) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Apyx Medical (APYX) | United States | $0.072B | 0.00 |
| Veru (VERU) | United States | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 50.71 |
| United-Guardian (UG) | United States | $0.036B | 12.38 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |